Marinus Pharmaceuticals Inc

NASDAQ:MRNS  
18.49
+0.35 (+1.93%)
Earnings Announcements

Marinus Pharmaceuticals Reports Qtrly Loss Per Share Of $0.74

Published: 05/17/2021 11:43 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Inc - at March 31, 2021, Had Cash, Cash Equivalents, and Investments of $123.5 Million, Compared to $140 Million at December 31, 2020.
Revenue is expected to be $2.63 Million
Adjusted EPS is expected to be -$0.69

Next Quarter Revenue Guidance is expected to be $2.84 Million
Next Quarter EPS Guidance is expected to be -$0.72

More details on our Analysts Page.